Research Article
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
Table 2
Disease-free survival (DFS) rate of stages I and II melanoma patients according to MIA serum concentration.
| MIA ng/mL | Number of patients | Number of relapses | 1-year DFS | 2-year DFS | 3-year DFS | 4-year DFS | Mean DFS (95% CI) | Median DFS (95% CI) |
| ≥9.4 | 24 | 16 | 79.2% | 58.3% | 35.4% | 30.3% | 2.4 years 1.7–2.9 | 2.2 years 0.9–3.5 | <9.4 | 60 | 3 | 98.3% | 94.5% | 94.5% | 94.5% | 4.4 years 4.1–4.6 | — |
|
|